A

Etanercept is a recombinant soluble p75 TNF-α receptor–IgG fusion protein that binds and neutralizes tumor necrosis factor-α (and β), thereby blocking TNF-mediated inflammatory signaling in rheumatoid arthritis [Fujikawa, 2007, PMID 17642234].